MARKHAM, ON, July 11, 2018 /CNW/ – MedReleaf Corp. announced that it has received certification under the European Medical Agency’s Good Manufacturing Practices Standards for its Markham facility from authorities in Cologne, Germany to make a first export of its products into Germany and has completed its first shipment of medical cannabis to Cannamedical Pharma GmbH.
“With the completion of our first shipment to Germany and ongoing shipments scheduled, MedReleaf is already among the leading exporters of cannabis to the European Union,” said Neil Closner, CEO of MedReleaf.
Full Article: newswire.ca